Saturday, 28 May 2022

 

 

LATEST NEWS Army vehicle fell into Shyok river Ladakh, 7 killed & several injured Decision to sell land adjacent to Patiala's historical Shri Kedarnath temple completely anti-people : Preneet Kaur The Title Of Akshay Kumar & Manushi Chhillar’s Prithviraj Changed. View Inside Punjab Increases Rates Of Group Insurance Scheme For Govt Employees 7 soldiers killed, 19 injured in Ladakh road accident IPL 2022: Things are falling in place for Royal Challengers Bangalore, says Sanjay Manjrekar French Open : Diego Schwartzman dispatches Grigor Dimitrov, moves to fourth round Deepika Padukone shares heartwarming 'Period Story' to raise awareness PWD Minister Harbhajan Singh ETO conducts surprise checking at Sector 17 offices of department Launch mass movement to save water : Punjab Chief Minister Bhagwant Mann Bollywood Stars Come Forward For The Promotions Of Qureshi Productions' DEHATI DISCO; Now in theatres Test cricket on downward trend, England can really change it : Brendon McCullum Smriti Irani slams Gandhis, says chants of 'Shri Ram' must reach them Udit Narayan shares his experience watching Anuradha Paudwal sing for the first time SS Rajamouli releases glimpse of 'Brahmastra's first song I will consider myself lucky to die alone : Samantha Ruth Prabhu in response to a troll IPL 2022 : Faf du Plessis, Virat Kohli, Glenn Maxwell will have to score runs for Royal Challengers Bangalore to win against Rajasthan Royals, says Akash Chopra Akshay Kumar : I have done almost 650 songs in my career, and I don't ever want to retire Daniel Bruhl, Macaulay Culkin join pandemic thriller 'Rich Flu' Zayn Ibad Khan, Khushi Dubey open up on being part of Hotstar Specials 'Aashiqana' 'The Broken News' trailer exposes gritty reality of the news business

 

This antiviral drug blocks Covid virus within 24 hrs: Study

Web Admin

Web Admin

5 Dariya News

New York , 05 Dec 2020

Researchers have discovered that the treatment of SARS-CoV-2 infection (Covid-19) with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses the virus transmission within 24 hours.According to the study, published in the journal Nature Microbiology, the research team from Georgia State University (GSU) originally discovered that the drug is potent against influenza viruses."This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission. MK-4482/EIDD-2801 could be game-changing," said study author Richard Plemper from GSU.Because the drug can be taken by mouth, treatment can be started early for a potentially three-fold benefit: inhibit patients' progress to severe disease, shorten the infectious phase to ease the emotional and socio-economic toll of prolonged patient isolation and rapidly silence local outbreaks,"We noted early on that MK-4482/EIDD-2801 has broad-spectrum activity against respiratory RNA viruses and that treating infected animals by mouth with the drug lowers the amount of shed viral particles by several orders of magnitude, dramatically reducing transmission," said Plemper."These properties made MK-4482/EIDD/2801 a powerful candidate for pharmacologic control of Covid-19," Plemper added.In the study, the research team repurposed MK-4482/EIDD-2801 against SARS-CoV-2 and used a ferret model to test the effect of the drug on halting virus spread.The team believe ferrets are a relevant transmission model because they readily spread SARS-CoV-2, but mostly do not develop severe disease, which closely resembles SARS-CoV-2 spread in young adults.The researchers infected ferrets with SARS-CoV-2 and initiated treatment with MK-4482/EIDD-2801 when the animals started to shed virus from the nose."When we co-housed those infected and then treated source animals with untreated contact ferrets in the same cage, none of the contacts became infected," said study co-author Josef Wolf.If these ferret-based data translate to humans, Covid-19 patients treated with the drug could become non-infectious within 24 hours after the beginning of treatment."MK-4482/EIDD-2801 is in advanced phase II/III clinical trials against SARS-CoV-2 infection," the authors wrote.

 

Tags: Health , Study , New York , Research , Researchers , World News , Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , COVAXIN , COVISHIELD , Covid-19 Vaccine , Covid-19 Vaccine in India

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD